Search

everythinglearnresearchcommunity

for

Search:↓

Belimumab effectively reduces disease activity in lupus patients, regardless of initial serologic status.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Injecting anti-herpes antibodies locally can prevent skin lesions and sweating problems caused by herpes simplex virus in mice.

Botox is effective for urinary incontinence, chronic migraines, and male pattern hair loss, and a new test for Botox antibodies is more humane.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

B cells can both help and hinder the body's defense against melanoma.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Tocilizumab might be an effective treatment for COVID-19.

Four antibodies were developed to help study hair follicle cell differentiation.

Langerhans cells and melanocytes migrate to the skin and hair follicles during early human development.

The study suggests that complement activation, not immunoglobulins, may be important in erythema nodosum leprosum.

Anti-CD19 therapy may help treat SLE and NMOSD.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Oxidative stress contributes to hair graying and loss as we age.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

The conclusion suggests that treatments targeting root causes of chronic diseases may be developed by focusing on gene expression and lifestyle factors.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Patients with thyroid disorders show different symptoms and antibody levels.

Immunoadsorption successfully treated a man's resistant polymyositis.

Belimumab effectively controls SLE disease activity and reduces steroid use.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

Avian yolk antibodies offer a promising, ethical alternative for disease prevention and therapy.

Belimumab may cause hair loss in lupus patients.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Canakinumab's effect on COVID-19 outcomes is unclear.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.